Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Bionano Genomics NASDAQ BNGO
$0.79 0.03 3.45%
Today share price
USA
Sector: Healthcare Industry: Life Sciences Tools & Services
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 22 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

35.97M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
63.67M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.98
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
45.75M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-58.41 %
Upcoming events Bionano Genomics All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Bionano Genomics

Stock analysis Bionano Genomics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.15 27.67
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.37 5.21
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.32 22.73
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.14 0.47
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-241.78 13.20

Price change Bionano Genomics per year

0.47$ 15.69$
Min Max

Summary analysis Bionano Genomics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Bionano Genomics

Revenue and net income Bionano Genomics

All parameters
Stock news Bionano Genomics All news
13 November 2023 в 15:55

Bionano Genomics downgraded to hold from buy at Maxim Group

30 August 2023 в 22:10

Bionano Genomics Shares Rise 13% After Publication of CRISPR-Cas9 Genome Mapping Study in 'Nature Communications'

30 August 2023 в 22:10

Bionano Genomics Shares Rise 13% After Publication of CRISPR-Cas9 Genome Mapping Study in 'Nature Communications'

14 August 2023 в 22:20

Bionano Genomics Falls to 52-Week Low After CFO Change News

14 August 2023 в 22:20

Bionano Genomics Falls to 52-Week Low After CFO Change News

13 March 2023 в 15:21

Bionano Genomics Discloses $2.1 Million in Accounts With SVB

13 March 2023 в 15:16

Bionano Genomics Discloses $2.1 Million in Accounts With SVB

13 March 2023 в 15:05

Bionano Genomics’ cash in SVB accounts represented about 41% of its cash and cash equivalents at yearend

18 March 2022 в 18:36

Bionano Genomics Shares Higher After Study Results

18 March 2022 в 18:36

Bionano Genomics Shares Higher After Study Results

14 February 2022 в 16:20

Bionano Genomics Names Helene Klein Chief People Officer

14 February 2022 в 16:20

Bionano Genomics Names Helene Klein Chief People Officer

12 October 2021 в 15:10

Bionano Genomics to Buy BioDiscovery for Up to $100 Million >BNGO

12 October 2021 в 15:05

Bionano Genomics to Buy BioDiscovery for Up to $100 Million >BNGO

7 November 2019 в 16:26

ЛИДЕРЫ УОЛЛ-СТРИТ-E.L.F Beauty, Bionano Genomics, Inflarx NV

18 October 2019 в 18:24

ЛИДЕРЫ УОЛЛ-СТРИТ-Bionano Genomics, Attis Industries, Apache

About company Bionano Genomics

Bionano Genomics, Inc., a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Its Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. The company also provides diagnostic testing for those with autism spectrum disorder and other neurodevelopmental disabilities. In addition, it offers an agnostic cross-platform data interpretation and clinical reporting software that integrates next-generation sequencing and microarray data, and provides visualization of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome for a fully integrated analysis in one view. The company was founded in 2006 and is headquartered in San Diego, California.
Address:
9540 Towne Centre Drive, San Diego, CA, United States, 92121
Company name: Bionano Genomics
Issuer ticker: BNGO
ISIN: US09075F1075
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-08-21
Sector: Healthcare
Industry: Life Sciences Tools & Services
Site: https://bionanogenomics.com

On which stock exchange are Bionano Genomics (BNGO) stocks traded?

Bionano Genomics (BNGO) stocks are traded on NASDAQ.

What is the ticker of Bionano Genomics stocks (BNGO)?

The stock ticker of Bionano Genomics’s stocks or in other words, the code is BNGO. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Bionano Genomics (BNGO) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Bionano Genomics (BNGO) belongs to the «Healthcare» sector and the «Life Sciences Tools & Services» industry.

In what currency are Bionano Genomics (BNGO) stocks traded?

Bionano Genomics (BNGO) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Bionano Genomics (BNGO) stocks today?

The current price of Bionano Genomics stocks on 29.04.2024 is 0.7861 dollars. per share.

What is the dynamics of Bionano Genomics (BNGO) stocks from the beginning of the year?

Bionano Genomics (BNGO) quotes have increased by -60.7% from the beginning of the year up to 0.7861 dollars. per 1 stocks.

How much did Bionano Genomics (BNGO) stocks increase in апреле 2024?

This month Bionano Genomics (BNGO) quotes have increased by -26.53% to 0.7861 dollars. per share.

How much are Bionano Genomics (BNGO) stocks worth?

Today, on October, 29.04.2024 Bionano Genomics’s (BNGO) stocks cost 0.7861 dollars..

What is the market capitalization of Bionano Genomics (BNGO)?

Capitalization is the market value of Bionano Genomics (BNGO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Bionano Genomics (BNGO) is estimated at about 35965647 dollars.